project id: TCGA-SKCM; case submitter id: TCGA-FS-A1ZS; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.83; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.7; rna integrity number: 9.1; age at index: 54; days to birth: -19813; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1944; age at diagnosis: 19813; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage I; ajcc pathologic t: T2; ajcc staging system edition: 5th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 4526.0; icd 10 code: C77.9; last known disease status: not reported; morphology: 8720/3; primary diagnosis: Malignant melanoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lymph node, NOS; synchronous malignancy: No; tissue or organ of origin: Skin, NOS; tumor grade: Not Reported; year of diagnosis: 1998; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 4822; initial weight: 140.0; oct embedded: false; preservation method: Unknown; sample id: 4b61f2eb-276c-4ec8-bce0-e6e3ac0dd1f6; sample submitter id: TCGA-FS-A1ZS-06A; portion id: fcb92441-e7bf-4cc0-a33f-5e3f5a5b068c; portion submitter id: TCGA-FS-A1ZS-06A-12; slide id: 473f46a3-da66-480e-9b18-c72f8e247856; slide submitter id: TCGA-FS-A1ZS-06A-01-TSA; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 95.0; section location: TOP;